Frontlight ResearchEarly access
Colorectal cancer trials in China
616 trials · From ClinicalTrials.gov, checked 16 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peopleCadonilimab in Combination With Bevacizumab and FOLFOX Regimen for the First-Line Treatment of Advanced Unresectable MSS-Type, RAS-Mutated Metastatic Colorectal Cancer
- Where
- Shanghai
- Age
- 18 years to 75 years
- People
- 53
- Run by
- Fudan University
See details and how to joinNCT06218810 - No phaseTaking peopleMRD-guided Deferred Adjuvant Therapy in Resectable Early-stage Colon Cancer
- Where
- Guangzhou
- Age
- 18 years to 70 years
- People
- 349
- Run by
- Sun Yat-sen University
See details and how to joinNCT06204484 - No phaseTaking peopleReasons for Non-reversal of Temporary Stomas After Surgeries of Mid-low Rectal Cancer (NORESTO Study)
- Where
- Beijing
- Age
- 18 years to 100 years
- People
- 235
- Run by
- Peking Union Medical College Hospital
See details and how to joinNCT06194708 - Phase 1/2Not yet taking people in ChinaClinical Study of Short-course Radiotherapy Followed by Fruquintinib Plus Sintilimab vs Bevacizumab Plus Capecitabine as First Line Treatment in Advanced mCRC
- Where
- Hangzhou
- Age
- 18 years to 85 years
- People
- 220
- Run by
- Zhejiang Cancer Hospital
See details and how to joinNCT06195670 - Phase 2Taking peopleEfficacy and Safety of Combined With Immunotherapy After Induction Therapy With Chemotherapy and Targeted Therapy in the First-line Treatment of Microsatellite Stable (MSS) Initially Unresectable Metastatic Colorectal Cancer
- Where
- Jinhua
- Age
- 18 years to 75 years
- People
- 36
- Run by
- yue junhan
See details and how to joinNCT06176885 - Phase 2Not yet taking people in ChinaCVL237 Tablets in the Treatment of Advanced Solid Tumors With PTEN Deficiency
- Where
- Beijing
- Age
- 18 years to 75 years
- People
- 98
- Run by
- Convalife (Shanghai) Co., Ltd.
See details and how to joinNCT06183736 - Phase 2Taking peopleCadonilimab Combined With Fruquintinib and SBRT as Athird-line and Posterior Line Treatment in Patients With MSS CRC
- Where
- Wuhan
- Age
- 18 years to 75 years
- People
- 40
- Run by
- Huazhong University of Science and Technology
See details and how to joinNCT06168786 - Phase 2Taking peopleMaintenance Tislelizumab + Capecitabine to Treat Metastatic Colorectal Cancer
- Where
- Guangzhou
- Age
- 18 years to 80 years
- People
- 52
- Run by
- Yanhong Deng
See details and how to joinNCT05360277 - No phaseTaking peopleProximally Extended Resection for Rectal Cancer After Neoadjuvant Chemoradiotherapy
- Where
- Guangzhou
- Age
- 18 years to 75 years
- People
- 240
- Run by
- Sixth Affiliated Hospital, Sun Yat-sen University
See details and how to joinNCT02649647 - No phaseEnrolling by invitationChemotherapy Combined With High-dose Radiotherapy for Low Rectal Cancer Using MR Guided Linear Accelerator
- Where
- Guangzhou
- Age
- 18 years to 80 years
- People
- 58
- Run by
- Sun Yat-sen University
See details and how to joinNCT05338866 - Phase 1Taking peopleClinical Study of CEA Targeting Chimeric Antigen Receptor T Lymphocytes(CAR-T) for CEA Positive Advanced Malignant Solid Tumors
- Where
- Wuhu
- Age
- 18 years and over
- People
- 60
- Run by
- Chongqing Precision Biotech Co., Ltd
See details and how to joinNCT06126406 - Phase 2Not yet taking people in ChinaThe Efficacy and Safety of TAS-102(Suyuan) Combined With Bevacizumab as First-line Therapy in Patients With Advanced Colorectal Cancer
- Where
- Tai’an
- Age
- 18 years to 85 years
- People
- 50
- Run by
- The Second Affiliated Hospital of Shandong First Medical University
See details and how to joinNCT06092242 - No phaseNot yet taking people in ChinaObservational Study for SIR-Spheres Therapy for the Treatment of Unresectable Metastatic Liver Tumors From Primary Colorectal Cancer
- Where
- Hangzhou
- Age
- 18 years and over
- People
- 200
- Run by
- GrandPharma (China) Co., Ltd.
See details and how to joinNCT06079242 - Phase 2Taking peopleNeoadjuvant Chemoradiotherapy Plus Sintilimab for Intermediate/High Immunoscore Locally Advanced Rectal Cancer
- Where
- Guangzhou
- Age
- 18 years to 75 years
- People
- 51
- Run by
- Yanhong Deng
See details and how to joinNCT05450029 - Phase 1Taking peopleA Clinical Trial Targeting CEA Chimeric Antigen Receptor T (CAR-T) for CEA Positive Advanced Malignant Solid Tumors
- Where
- Hangzhou
- Age
- 18 years and over
- People
- 30
- Run by
- Chongqing Precision Biotech Co., Ltd
See details and how to joinNCT06043466 - No phaseTaking peopleSalvage Chemotherapy Versus Total Mesorectal Resection for Local Resection Rectal Cancer Patients
- Where
- Guangzhou
- Age
- 18 years to 75 years
- People
- 392
- Run by
- Sun Yat-sen University
See details and how to joinNCT06043999 - Phase 2Taking peopleCetuximab Plus Irinotecan in Patients With NeoRAS Wild-type Metastatic Colorectal Cancer In Third-line Therapy
- Where
- Guangzhou
- Age
- 18 years and over
- People
- 54
- Run by
- Sun Yat-sen University
See details and how to joinNCT05962502 - No phaseTaking peopleA Community Population Screening Cohort Study Based on Polygene Methylation Detection for Colorectal Cancer in Yangzhou
- Where
- Yangzhou
- Age
- 40 years to 74 years
- People
- 80,000
- Run by
- Singlera Genomics Inc.
See details and how to joinNCT05336539 - No phaseNot yet taking people in ChinaFluorescence Laparoscopic Navigation for Rectal Cancer and Sigmoid Colon Cancer
- Where
- Beijing, Binzhou, Changchun, Chengdu, Fuzhou, Guangzhou, Haerbin, Hefei, Kunming, Nanchang, Nanjing, Shanghai, Shenyang, Shijiazhuang, Taiyuan, Xining, Yibin
- Age
- 18 years to 75 years
- People
- 550
- Run by
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT05730595 - No phaseTaking peopleChoice of the Optimal Treatment Strategies for Mid-low REctal Cancer
- Where
- Beijing
- People
- 3,705
- Run by
- Peking Union Medical College Hospital
See details and how to joinNCT05871762 - No phaseTaking peopleOptical Biopsy for Peritoneal Nodules in Colorectal Patients
- Where
- Guangzhou
- Age
- 18 years to 85 years
- People
- 278
- Run by
- Nanfang Hospital, Southern Medical University
See details and how to joinNCT05879783 - Phase 2Not yet taking people in ChinaKN026 Plus Chemotherapy ± KN-046 in HER2 Positive Colorectal Cancer and Biliary Carcinoma
- Where
- Beijing
- Age
- 18 years and over
- People
- 80
- Run by
- Peking University Cancer Hospital & Institute
See details and how to joinNCT05985707 - Phase 3Taking peopleThe Efficacy of Primary Total Mesorectal Excision (TME) Surgery Versus Neoadjuvant Chemotherapy Combined With TME Surgery in Low-risk Locally Advanced Rectal Cancer
- Where
- Chongqing, Guangzhou, Hengyang, Nanchong, Shenyang, Xi’an
- Age
- 18 years to 75 years
- People
- 766
- Run by
- Sun Yat-sen University
See details and how to joinNCT05984485 - Phase 2Taking peopleInduction Chemotherapy Combined With Neoadjuvant Immunotherapy for MSS Colon Cancer
- Where
- Hangzhou
- Age
- 18 years to 75 years
- People
- 100
- Run by
- Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT05914389 - Phase 2Not yet taking people in ChinaOrgan Preservation Following Enverolimab-based Total Neoadjuvant Therapy for Locally Advanced Very Low Rectal Cancer
- Where
- Fuzhou
- Age
- 18 years to 75 years
- People
- 72
- Run by
- 池畔
See details and how to joinNCT05969847